Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
CALL
Under Armour
UAA
$2.6B
| $18.7M | 0.01% |
+1,837,600
| New | +$15.9M |
|
927
Dentsply Sirona
XRAY
$2.43B
| $18.7M | 0.01% |
586,081
+357,361
| +156% | +$10.8M |
|
928
Generac Holdings
GNRC
$12.5B
| $18.6M | 0.01% |
185,072
+51,811
| +39% | +$5.86M |
|
929
Neurocrine Biosciences
NBIX
$16.6B
| $18.6M | 0.01% |
155,786
+9,183
| +6% | +$1.08M |
|
930
Royal Bank of Canada
RY
$293B
| $18.6M | 0.01% |
197,792
-50,826
| -20% | -$4.8M |
|
931
CALL
Tapestry
TPR
$32.8B
| $18.5M | 0.01% |
+487,000
| New | +$16.7M |
|
932
Sunrun
RUN
$2.46B
| $18.5M | 0.01% |
769,637
+310,832
| +68% | +$8.3M |
|
933
PUT
Target
TGT
$68B
| $18.5M | 0.01% |
123,800
-50,400
| -29% | -$7.91M |
|
934
CALL
Kraft Heinz
KHC
$30B
| $18.4M | 0.01% |
+453,100
| New | +$17.2M |
|
935
Liberty Media Series C
FWONK
$25.8B
| $18.4M | 0.01% |
317,730
-339,077
| -52% | -$19.4M |
|
936
Qorvo
QRVO
$8.74B
| $18.2M | 0.01% |
201,272
-80,357
| -29% | -$7.26M |
|
937
Cytokinetics
CYTK
$10.4B
| $18.2M | 0.01% |
397,187
-4,066
| -1% | -$175K |
|
938
CALL
Gilead Sciences
GILD
$165B
| $18.1M | 0.01% |
+210,400
| New | +$16.7M |
|
939
Natera
NTRA
$46.4B
| $18M | 0.01% |
447,607
+341,396
| +321% | +$14.1M |
|
940
Kohl's
KSS
$2.19B
| $18M | 0.01% |
711,705
+458,327
| +181% | +$13M |
|
|
MGI
941
DELISTED
MoneyGram International, Inc. New
MGI
| $17.9M | 0.01% |
1,642,643
+358,388
| +28% | +$3.83M |
|
942
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.7M
| $17.9M | 0.01% |
172,811
| – | – |
|
943
PUT
Salesforce
CRM
$158B
| $17.8M | 0.01% |
+134,400
| New | +$19.6M |
|
944
TORM
TRMD
$3.02B
| $17.8M | 0.01% |
608,884
+184,608
| +44% | +$4.98M |
|
945
Zebra Technologies
ZBRA
$17.8B
| $17.7M | 0.01% |
69,192
+14,665
| +27% | +$3.79M |
|
946
Vanguard Total Bond Market
BND
$161B
| $17.7M | 0.01% |
246,634
-20,841
| -8% | -$1.49M |
|
947
Masco
MAS
$15.3B
| $17.7M | 0.01% |
378,683
+103,500
| +38% | +$4.99M |
|
948
CALL
Nike
NKE
$61.9B
| $17.6M | 0.01% |
+150,500
| New | +$15.2M |
|
949
Rio Tinto
RIO
$164B
| $17.6M | 0.01% |
246,606
-56,943
| -19% | -$3.58M |
|
950
PUT
General Mills
GIS
$19.7B
| $17.5M | 0.01% |
+209,000
| New | +$17M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.